cp wire

CP Wire Articles

[release] Following approval in Sweden, Lobsor eyes US entry for new Lecigon treatment for Parkinson’s Disease
Uppsala, October 8, 2018. Lobsor Pharmaceuticals AB, a privately held Swedish company based in Uppsala today announced that Lecigon®, a new therapeutic system for symptomatic treatment... read more
Mon, 10/8/18 - 10:08 am
Bacteriophage Company AmpliPhi Presents Positive Data on Expanded Access Program for Serious S. aureus Infections
  • 10 of 12 patients achieved treatment success
  • AB-SA01 was well tolerated with no adverse events attributable to AB-SA01
  • Initial gene expression data indicate that... read more
Mon, 10/8/18 - 09:49 am
Exelixis Begins Ph III Trial of Cabometyx in Refractory Thyroid Cancer
  • Thyroid cancer is the most rapidly increasing cancer diagnosis in the US with incidence tripling over the last 30 years
  • Cabometyx is approved for renal cell carcinoma and... read more
Mon, 10/8/18 - 09:25 am
Aytu Prices Upcoming Public Offering at 13.2 Million
  • The company currently markets Natesto, the only FDA-approved nasal formulation of testosterone for men with hypogonadism (low testosterone, or "Low T")
  • Aytu also recently acquired... read more
Fri, 10/5/18 - 10:24 am
Amicus Announces Positive Results for AT-GAA in Pompe Disease
  • Muscle funtion improved in 17 of 19 patients at month 12
  • Treatment with AT-GAA resulted in persistent and durable reductions in key biomarkers of muscle damage across all patient... read more
Fri, 10/5/18 - 09:46 am

Pages